Our company are interested to purchase a wide range of pharmaceutical products: Oncology products, COVID-19 medications (treatments & vaccines), Antiviral/Antibacterial medications, Orphan drugs, NCD drugs, vaccine products, gene therapy products such as treatments or medicines for Duchenne muscular dyst...
(HPAPIs), particularly in targeted therapies for oncology indications. The rise in demand for generic drugs and biologics, coupled with the capital-intensive nature of API manufacturing and complex production requirements, has led many pharmaceutical companies to rely on CMOs for their API needs. ...
As per the scope of the report, pharmaceutical intermediates are the drugs used as raw materials for the production of bulk drugs, or they can refer to a material produced during the synthesis of an API that must undergo further molecular change or processing before it becomes an API. The P...
21. Rolvedon eflapegrastim 9/9/2022 To decrease the incidence of infection in patients with non-myeloid malignancies receiving myelosuppressive anti-cancer drugs associated with clinically significant incidence of febrile neutropenia 20. Sotyktu deucravacitinib 9/9/2022 To treat moderate-to-severe ...
21. Rolvedon eflapegrastim 9/9/2022 To decrease the incidence of infection in patients with non-myeloid malignancies receiving myelosuppressive anti-cancer drugs associated with clinically significant incidence of febrile neutropenia 20. Sotyktu deucravacitinib 9/9/2022 To treat moderate-to-severe ...
Teva Pharmaceutical Industries is one of the largest generic drug manufacturers in the world. In 2024, the company reported a total revenue of around 16.5 billion U.S. dollars. This statistic shows the revenue of pharmaceutical company Teva in the years 2006 to 2024. ...
(Prescription Drugs and Over-the-Counter), Usage (Clinical and Research), Potency (Low-to-Moderate Potency Active Pharmaceutical Ingredients and Potent-to-Highly Potent Active Pharmaceutical Ingredient), Therapeutic Application (Cardiology, CNS and Neurology, Oncology, Orthopedic, Endocrinology, Pulmonology...
Ultimately, outsourcing manufacturing to experienced partners In these countries can lead to significant advancements in the production of drug products for chronic diseases, personalized medicine, technology transfer, and generic drugs. What are the market trends shaping the CMO In Pharmaceutical Industry ...
The biopharmaceutical sector is quickly developing as a result of the need for drugs that can change the course of therapy, which is creating issues in the healthcare system. Pharmaceutical research advancements will have a substantial impact on the growth of the API industry. ...
Our company are interested to purchase a wide range of pharmaceutical products: Oncology products, COVID-19 medications (treatments & vaccines), Antiviral/Antibacterial medications, Orphan drugs, NCD drugs, vaccine products, gene therapy products such as treatments or medicines for Duchenne muscular dyst...